Sessa Capital (Master), L.P. - Insider Non-Derivative Transactions at SAB Biotherapeutics, Inc. (SABS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 24, 2023, Sessa Capital (Master), L.P.'s relationship to SAB Biotherapeutics, Inc. (SABS) is Director, and currently has 4,584,571 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SABS insiders.
Data Source: SEC.
Sessa Capital (Master), L.P. - Insider Non-Derivative Transactions at SABS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 25, 2023 | M -- (Common Stock) | 4584571 | 0 | 4584571 |